Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Gates Foundation Honors 2023 Goalkeepers Awardees, Announces Commitments to Advance the Sustainable Development Goals

Published

on

gates-foundation-honors-2023-goalkeepers-awardees,-announces-commitments-to-advance-the-sustainable-development-goals

Awardees include Japan Prime Minister Fumio Kishida, Rosalynn and Jimmy Carter, Bono, and activists from Cameroon, Ethiopia, and the United States

NEW YORK, Sept. 20, 2023 /PRNewswire/ — At its annual Goalkeepers events, the Bill & Melinda Gates Foundation announced this year’s Goalkeepers Global Goals Award winners, recognizing the contributions of six remarkable leaders working in their communities and around the world to advance progress towards the United Nations Sustainable Development Goals (UN SDGs).

The awards ceremony took place during UN General Assembly week on the evening of September 19. It was followed by a daytime event today to discuss current and future efforts to achieve the Global Goals through concrete action and new approaches to development finance. Participants included Prime Minister Fumio Kishida of Japan, President William Ruto of Kenya, Belgian Prime Minister Alexander De Croo, Bill Gates, Melinda French Gates, and more than 400 young changemakers from around the world.

Earlier this week, the foundation responded to an alarming reversal in progress on Global Goal 3 by announcing commitments totaling $200 million to help achieve universal access to family planning products and information, faster delivery of lifesaving health solutions, and a reduction in maternal and child mortality.

“Halfway to the deadline for the Sustainable Development Goals, our annual Goalkeepers Report shows that on 18 indicators—from poverty to gender equality, education to food security, health to climate—the world is off track,” said Mark Suzman, CEO of the Gates Foundation. “But we also see where innovation, investment, and the extraordinary work of passionate changemakers around the world have the potential to turn the tide, saving the lives of 2 million mothers and babies by 2030.”

The full text of the 2023 Goalkeepers Report can be found here: https://www.gatesfoundation.org/goalkeepers/report/2023-report/

Celebrating Global Goalkeepers
This year’s 2023 Goalkeepers Global Goals Awards Ceremony was hosted by Elaine Welteroth, award-winning journalist, TV host, and author, and was attended by global leaders, activists, and celebrities. The event included special performances by Tiwa Savage, Nigerian singer-songwriter and actress; Usha Jey, Tamil dancer and choreographer; Zara Larsson, Swedish singer-songwriter; and the Harlem Gospel Choir.

The daytime event featured special guests Jon Batiste, American musician and singer; David Oyelowo, actor, director, and producer; Titilope Sonuga, Nigerian poet and former poet laureate; and Sallie Krawcheck, founder of Ellevest. 

“This year’s Goalkeepers Global Goals Award winners show us how human ingenuity and innovation can help tackle some of the world’s most difficult challenges,” said Blessing Omakwu, deputy director, global content and campaigns and Goalkeepers lead. “Everyone has the power to make a difference in their communities, and these courageous and indefatigable advocates are helping tens of thousands of people live healthier, more productive lives.”

This year’s awards include:

  • The 2023 Global Goalkeeper Award, which recognizes a leader who has driven progress on a global scale toward achieving the Global Goals, was presented to the Prime Minister of Japan, Fumio Kishida, for championing resilient, equitable, and sustainable universal health coverage for all; embedding the Global Goals in Japan’s development cooperation charter; and strengthening the global health architecture to prevent future pandemics.
  • The 2023 Campaign Award, which celebrates a campaign that has raised awareness or built a community by inspiring action and creating change, was presented to The Farmlink Project, founded by Aidan Reilly, Ben Collier, and James Kanoff, for its work advocating for and building community around food equity in the United States. Through its network of more than 600 student fellows and 6,000 volunteers, The Farmlink Project has provided 83 million meals and transferred more than 130 million pounds of nutritious food to communities facing hunger.
  • The 2023 Changemaker Award, which celebrates an individual who has inspired change using personal experience or from a position of leadership, was presented to Ashu Martha Agbornyenty for her work reducing high rates of maternal mortality in Cameroon. She writes about the work of midwives and shares her knowledge on pregnancy through her blog, Marthie’s Midwifery Diary. Through her For Mom & Baby Foundation, she and her team provide community workshops and distribute emergency kits containing essential birth supplies to pregnant women in crisis-stricken areas, reaching 1,000 women and girls in the region since 2021.
  • The 2023 Progress Award, which celebrates an individual who supports progress via a science, technology, digital, or business initiative, was presented to journalist, social entrepreneur, digital innovator, and human rights activist Eden Tadesse. Tadesse founded the online platform Invicta, a global impact platform that promotes digital financial inclusion, skills development, and access to job opportunities for urban refugees. More than 35,000 people from 90 countries have registered on Invicta, with 7,000 of them completing online courses and more than 2,200 refugees finding employment.

Special recognition awards were presented to Rosalynn and Jimmy Carter and Bono for their tireless work over many decades towards global health and development.

  • The Goalkeepers Lifetime Achievement Award was given to former President Jimmy Carter and former First Lady Rosalynn Carter, honoring their extraordinary work on disease eradication, mental health, democracy, conflict resolution, human rights, and, most notably, combating neglected tropical diseases (NTDs) such as Guinea worm disease, river blindness, and malaria. The award was accepted on their behalf by Paige Alexander, CEO of the Carter Center, and Jason Carter, chair of the Carter Center Board of Trustees.
  • The Goalkeepers Voice Award was presented to Bono, founder of the ONE Campaign and (RED), lead singer of the band U2, and activist, for his significant impact on SDG progress through advocacy and campaigning with ONE and (RED).

Media assets, which include biographies, images, and videos of awardees, as well as photos from the awards ceremony, can be found here.

Accelerating Progress Toward the Global Goals
The Gates Foundation announced the following commitments this week:

  • Long-term commitment of up to $100 million to help meet the demand in low- and middle-income countries (LMICs) for family planning supplies. This funding will go to the UNFPA Supplies Partnership to ensure more women in LMICs are able to access the contraceptives they need and want at a price they can afford. Contraceptives are critical building blocks of women’s power and can accelerate progress toward nearly every SDG—whether that’s ending poverty or improving global health. This commitment comes at a time when the global funding gap for contraceptives is growing, with the potential to cumulatively reach $1 billion by 2030 if we do not preserve funding and bring in additional support, including through sustainable financing approaches.
  • Long-term commitment of $100 million to bring faster access to health products in low- and middle-income countries. This funding will go to Unitaid, doubling the foundation’s previous commitment, to support its work to accelerate the introduction and delivery of new lifesaving solutions at equitable scale, including those for maternal and newborn health. Unitaid’s unique approach helps reach the health-related targets of the Sustainable Development Goals more quickly. Its previous work unlocked access to more than 100 groundbreaking health products, including those for HIV, TB, and malaria; women’s and children’s health; and pandemic prevention, preparedness, and response.

About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Mark Suzman, under the direction of Co-chairs Bill Gates and Melinda French Gates and the board of trustees.

About Goalkeepers
Goalkeepers is the foundation’s campaign to accelerate progress towards the Sustainable Development Goals (Global Goals). By sharing stories and data behind the Global Goals through an annual report, the Gates Foundation hopes to inspire a new generation of leaders—Goalkeepers who raise awareness of progress, hold their leaders accountable, and drive action to achieve the Global Goals.

About the Global Goals
On September 25, 2015, at the United Nations headquarters in New York, 193 world leaders committed to the 17 Sustainable Development Goals (Global Goals). These are a series of ambitious objectives and targets to achieve three extraordinary things by 2030: end poverty, fight inequality and injustice, and fix climate change.

Media Contact: [email protected]

View original content:https://www.prnewswire.co.uk/news-releases/gates-foundation-honors-2023-goalkeepers-awardees-announces-commitments-to-advance-the-sustainable-development-goals-301932487.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending